AI assistant
Sending…
Nuvectis Pharma, Inc. — Director's Dealing 2024
Dec 16, 2024
33912_dirs_2024-12-16_b223c5f0-61a8-4db5-b763-463383e54365.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2024-12-13
Reporting Person: Mosseri Marlio Charles (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-13 | Common Stock | P | 17000 | $4.70 | Acquired | 2612000 | Direct |
More from Nuvectis Pharma, Inc.
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Feb 23
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Feb 11
Annual Report
2026
Feb 11
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9